Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 25% ± 6% | |
glutamatergic neuron | 4 studies | 40% ± 20% | |
endothelial cell | 3 studies | 23% ± 1% | |
lymphocyte | 3 studies | 17% ± 2% | |
GABAergic neuron | 3 studies | 37% ± 13% | |
abnormal cell | 3 studies | 21% ± 6% | |
enteroendocrine cell | 3 studies | 25% ± 7% | |
interneuron | 3 studies | 38% ± 16% | |
oligodendrocyte | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1320.76 | 21 / 21 | 100% | 23.44 | 504 / 504 |
brain | 100% | 1715.52 | 2642 / 2642 | 100% | 26.02 | 705 / 705 |
esophagus | 100% | 1456.39 | 1445 / 1445 | 100% | 21.11 | 183 / 183 |
intestine | 100% | 1562.62 | 966 / 966 | 100% | 24.41 | 527 / 527 |
ovary | 100% | 1191.68 | 180 / 180 | 100% | 23.42 | 430 / 430 |
stomach | 100% | 1275.55 | 359 / 359 | 100% | 23.58 | 286 / 286 |
uterus | 100% | 1388.13 | 170 / 170 | 100% | 24.73 | 459 / 459 |
breast | 100% | 1221.91 | 459 / 459 | 100% | 28.82 | 1117 / 1118 |
prostate | 100% | 1168.81 | 245 / 245 | 100% | 14.66 | 500 / 502 |
thymus | 100% | 1255.04 | 653 / 653 | 100% | 20.82 | 602 / 605 |
lung | 99% | 1108.45 | 575 / 578 | 100% | 22.76 | 1155 / 1155 |
kidney | 100% | 989.16 | 89 / 89 | 99% | 15.82 | 895 / 901 |
skin | 100% | 1296.55 | 1809 / 1809 | 99% | 22.14 | 468 / 472 |
pancreas | 99% | 727.32 | 326 / 328 | 99% | 20.57 | 177 / 178 |
adrenal gland | 100% | 1020.03 | 258 / 258 | 99% | 19.39 | 227 / 230 |
liver | 100% | 643.61 | 226 / 226 | 95% | 11.56 | 387 / 406 |
adipose | 100% | 1219.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1170.60 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.26 | 29 / 29 |
muscle | 100% | 1825.30 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1954.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.76 | 1 / 1 |
heart | 98% | 919.29 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 10.18 | 77 / 80 |
peripheral blood | 95% | 1591.64 | 880 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_2001271 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GO_2000374 | Biological process | regulation of oxygen metabolic process |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070417 | Biological process | cellular response to cold |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0006915 | Biological process | apoptotic process |
GO_1902042 | Biological process | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0035872 | Biological process | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
GO_1901797 | Biological process | negative regulation of signal transduction by p53 class mediator |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0002039 | Molecular function | p53 binding |
GO_0046872 | Molecular function | metal ion binding |
GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RNF34 |
Protein name | Ring finger protein 34 RING-type E3 ubiquitin transferase (EC 2.3.2.27) E3 ubiquitin-protein ligase RNF34 (EC 2.3.2.27) (Caspase regulator CARP1) (Caspases-8 and -10-associated RING finger protein 1) (CARP-1) (FYVE-RING finger protein Momo) (Human RING finger homologous to inhibitor of apoptosis protein) (hRFI) (RING finger protein 34) (RING finger protein RIFF) (RING-type E3 ubiquitin transferase RNF34) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase that regulates several biological processes through the ubiquitin-mediated proteasomal degradation of various target proteins. Ubiquitinates the caspases CASP8 and CASP10, promoting their proteasomal degradation, to negatively regulate cell death downstream of death domain receptors in the extrinsic pathway of apoptosis . May mediate 'Lys-48'-linked polyubiquitination of RIPK1 and its subsequent proteasomal degradation thereby indirectly regulating the tumor necrosis factor-mediated signaling pathway (Ref.13). Negatively regulates p53/TP53 through its direct ubiquitination and targeting to proteasomal degradation . Indirectly, may also negatively regulate p53/TP53 through ubiquitination and degradation of SFN . Mediates PPARGC1A proteasomal degradation probably through ubiquitination thereby indirectly regulating the metabolism of brown fat cells . Possibly involved in innate immunity, through 'Lys-48'-linked polyubiquitination of NOD1 and its subsequent proteasomal degradation . . |
Accessions | ENST00000557402.1 G3V504 G3V4D1 ENST00000555076.1 ENST00000392465.7 [Q969K3-2] ENST00000554868.1 Q969K3 ENST00000392464.3 H7BYJ1 A0A087WTM5 ENST00000554606.5 ENST00000613529.4 G3V5F1 ENST00000361234.10 [Q969K3-1] G3V566 |